ArticleMolecular metabolism2026
Pik3ip1 mediates thyroid hormone-dependent regulation of the PI3K/Akt/mTOR axis in muscle atrophy.
Article in Molecular metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skeletal muscle atrophy is driven by an imbalance between anabolic and catabolic signaling pathways, often involving suppression of the PI3K/Akt/mTOR axis. Thyroid Hormones (THs) are key endocrine regulators of skeletal muscle metabolism and adaptation, exerting context-dependent effects that promote either muscle atrophy or hypertrophy. Here, we identify Phosphoinositide-3-kinase interacting protein 1, Pik3ip1, as a critical regulator of TH-dependent muscle homeostasis. Transcriptomic profiling of skeletal muscle from muscle-specific D2 knockout (mD2KO) and TH Receptor knockout (TRKO) mice revealed a catabolic transcriptional program associated with increased Pik3ip1 expression. Consistently, Pik3ip1 expression negatively correlated with TH signaling in vivo and in vitro. Functional studies in C2C12 myotubes showed that Pik3ip1 overexpression suppresses Akt/mTOR signaling, indicating that its induction is sufficient to impair anabolic pathway activation. In vivo, Pik3ip1 expression was rapidly induced during denervation-induced muscle atrophy and remained persistently elevated in mD2KO and TRKO muscles, characterized by altered TH signaling. Sustained Pik3ip1 expression was associated with impaired activation of the Akt/mTOR pathway and enhanced muscle wasting. Conversely, TH treatment reduced Pik3ip1 levels, restored Akt/mTOR signaling, and promoted anabolic responses. Forced Pik3ip1 expression attenuated TH-induced Akt/mTOR phosphorylation, confirming its role as a mediator of TH-dependent anabolic regulation. Collectively, these findings identify Pik3ip1 as a key negative regulator of PI3K/Akt/mTOR signaling in skeletal muscle and establish the TH-Pik3ip1 axis as an important mechanism controlling muscle mass maintenance during atrophic conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.